| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |